Physician profile
Daniel Alicea
NPI 1578094470
$4,740.97
in general payments reported to CMS, 2019-2025
7 companies · $1,125 in 2025
The $1,125 reported for 2025 was more than what 82% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,302 · 2023: $671 · 2024: $1,643 · 2025: $1,125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,278 · Consulting Fee: $750 · Travel and Lodging: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,278.23 |
| Consulting Fee | $750.00 |
| Travel and Lodging | $411.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurent Medical Limited | $1,294.41 | 2023-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Integra Lifesciences Corporation | $920.86 | 2024-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Medtronic, INC. | $792.76 | 2022-2025 | Stealthstation S8 Platform |
| Stryker Corporation | $714.81 | 2023-2025 | Scopis Ent, Xpress Ent Dilation System |
| Acclarent, INC | $625.12 | 2022-2023 | Trudi Nav Cable |
| Intersect Ent, INC. | $313.71 | 2022 | |
| Glaxosmithkline, LLC. | $79.30 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Alicea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.